A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates.
Journal article
Tanner R. et al, (2021), NPJ Vaccines, 6
Cytomegalovirus infection is a risk factor for tuberculosis disease in infants.
Journal article
Müller J. et al, (2019), JCI insight, 4
Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells.
Journal article
Tanner R. et al, (2019), Journal of Immunological Methods, 469, 1 - 10
Author Correction: The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.
Journal article
Tanner R. et al, (2019), Scientific reports, 9
The Humoral Immune Response to BCG Vaccination.
Journal article
Tanner R. et al, (2019), Frontiers in Immunology, 10
Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection.
Journal article
Tanner R. et al, (2019), Frontiers in immunology, 10
Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
Journal article
O’Shea MK. et al, (2018), Scientific Reports, 8
Meeting report: 5th Global Forum on TB Vaccines, 20–23 February 2018, New Delhi India
Conference paper
Atmakuri K. et al, (2018), Tuberculosis, 113, 55 - 64
Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
Journal article
McNeill E. et al, (2018), Nature Communications, 9
Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK
Journal article
Hayward S. et al, (2018), F1000Research, 7, 461 - 461
Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
Journal article
Harris SA. et al, (2018), Tuberculosis, 108, 99 - 105
Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection.
Journal article
O'Shea MK. et al, (2018), Frontiers in immunology, 9
A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
Journal article
Pepponi I. et al, (2017), Tuberculosis, 106, 118 - 122
The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010–2014
Journal article
Brennan MJ. et al, (2017), Clinical and Vaccine Immunology, 24
The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
Journal article
Tanner R. et al, (2017), Scientific Reports, 7
Replacing, reducing and refining the use of animals in tuberculosis vaccine research
Journal article
Tanner R., (2017), ALTEX, 157 - 166
TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development
Journal article
Kaufmann SHE. et al, (2017), Frontiers in Immunology, 8
A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis
Journal article
Zelmer A. et al, (2016), BMC Infectious Diseases, 16
Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study
Journal article
Fletcher HA. et al, (2016), BMC Medicine, 14
Erratum: Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants
Journal article
Fletcher HA. et al, (2016), Nature Communications, 7